Freezing and thawing of murine bone marrow-derived dendritic cells does not alter their immunophenotype and antigen presentation characteristics

Folia Biologica

Volumn 48, Issue 6, 2002, Pages 242-245

  Mendoza, L ^a   Bubenik J ^a   Indrova M ^a   Bieblova J ^a   Vonka, V ^b   Simova J ^a  

^a INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^b INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

Author keywords

DC priming; Dendritic cells; Tumour lysate

Indexed keywords

B7 ANTIGEN; CD11B ANTIGEN; CD86 ANTIGEN; DIMETHYL SULFOXIDE; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; THYMIDINE; TRITIUM; TUMOR VACCINE;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; BONE MARROW CELL; CANCER CELL CULTURE; CELL ADHESION; CELL COUNT; CELL CULTURE; CELL FUNCTION; CELL LYSATE; CELL STRUCTURE; CONTROLLED STUDY; CRYOPRESERVATION; CULTURE MEDIUM; DENDRITIC CELL; FETAL CALF SERUM; FREEZING; IMMUNOPHENOTYPING; IN VITRO STUDY; MITOGENESIS; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; SPLEEN CELL; STEM CELL; THAWING; WART VIRUS;

ANIMALIA; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; MURINAE;

EID: 0036915059     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Bubeník, J. (1999) Dendritic cell-based cancer vaccines (Editorial). Folia Biol. (Praha) 45, 71-74.
2. Bubeník, J., Den Otter, W., Huland, E. (2000) Local cytokine therapy of cancer: interleukin-2, interferons and related cytokines. Cancer Immunol. Immunother. 49, 116-122
3. Bubeník, J., Mikyšková, R., Vonka, V., Mendoza, L., Šímová, J., Šmahel, M., Indrová, A (2002) Interleukin-2 and dendritic cells as adjuvants for surgical therapy of tumours associated with human papillomavirus type 16. Vaccines (in press).
4. Indrová, M., Bubeník, J., Šímová, J., Vonka, V., Němečková, Š., Mendoza, L., Reiniš, M. (2001) Therapy of HPV 16-associated carcinoma with dendritic cell-based vaccines: in vitro priming of the effector cell responses by DC pulsed with tumour lysates and synthetic RAHYNIVTF peptide. Int. J. Mol. Med. 7, 97-100
5. Karasuyama, H., Melchers, F. (1988) Establishment of mouse cell lines which constitutively secrete large quantities of interleukin-2, 3, 4 or 5 using modified cDNA expression vectors. Eur J. Immunol. 18,97-104.
6. Mendoza, L., Indrová, M., Hájková, R., Reiniš, M., Šmahel, M., Vonka, V., Bubeník, J., Jandlová, T. (2000) Peritumoral administration of antigen-unstimulated bone marrow-derived dendritic cells inhibits tumour growth. Folia Biol. (Praha) 46, 91-97.
7. Mendoza, L., Bubeník, J., Šímová, J., Korb, J., Bieblová, J., Vonka, V., Indrová, M., Mikyšková, R., Jandlová, T. (2002) Tumour-inhibitory effects of dendritic cells administered at the site of HPV 16-associated neoplasms. Folia Biol. (Praha) 48, 114-119.
8. Šímová, J., Reiniš, M., Sobota, V., Čapková, J., Bubeník, J., Jandlová, T. (2000) Irradiation of geneticaly modified plasmacytoma vaccines results in upregulation of CD80 molecule expression, Il-2 production and higher therapeutic efficacy of the vaccines. Folia Biol. (Praha) 46, 11-16.
9. Šmahel, M., Sobotková, E., Bubeník, J., Žák, R., Ludvílcová, V., Hájková, R., Kovařík, J., Jelínek, - F., Povýšil, C., Marinov, J., Vonka, V. (2001) Metastatic MHC class I-negative mouse cells derived by transformation with human